Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | N/A | 8,630 |
| Other current assets | 0 | 0 | 30 |
| TOTAL | $N/A | $N/A | $8,660 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 420 |
| Other Non-Current Assets | 0 | 0 | 8 |
| TOTAL | $N/A | $N/A | $428 |
| Total Assets | $N/A | $N/A | $8,680 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 110 |
| Accrued Expenses | N/A | N/A | 370 |
| Other current liabilities | N/A | N/A | 1,340 |
| TOTAL | $N/A | $N/A | $4,490 |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $N/A | $4,490 |
| Shareholders' Equity | |||
| Common Shares | N/A | N/A | 1 |
| Retained earnings | N/A | N/A | -56,230 |
| Other shareholders' equity | 0 | 0 | 59,550 |
| TOTAL | $N/A | $N/A | $4,180 |
| Total Liabilities And Equity | $0 | $0 | $8,670 |